| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.24 | 8e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.095 | 0.1 |